INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Results for “Weight Loss Over Two”

Health
2 sources

Who is covering this

Google NewsCenterMedscapeCenter
Truth score 50
Centre 100%100%
Google NewsCenter

After a GLP-1: Which Exit Strategy Keeps the Weight Off?

After a GLP-1: Which Exit Strategy Keeps the Weight Off? Medscape Taking GLP-1s forever? 5 strategies to keep weight off if you stop American Council on Science and Health Switching Between Semaglutide and Tirzepatide Linked to 16%...

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
  • Medscape After a GLP-1: Which Exit Strategy Keeps the Weight Off?

    After a GLP-1, what works next? Among more than 20,000 patients, surgery was linked to the most weight loss, quitting cold the least, and switching from semaglutide to tirzepatide beat staying put. Medscape Medical News

    Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent50%
Google News50%
Avg reliability70
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 50 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 70 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 3 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily ExpressLeans right
Truth score 37
Right 100%100%
Daily ExpressLeans right

Brits given major warning over weight loss injections

Thousands of hopeful dieters are being urged to check their pens after a major raid uncovered dangerous fakes.

Lean: Leans right Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability62
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 62 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

BBC NewsCenter
Truth score 46
Centre 100%100%
BBC NewsCenter

'I'm lucky to be alive': Woman's warning over black market weight-loss jabs

Kay Roscoe was rushed to hospital after taking what she thought was the weight-loss drug retatrutide.

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
Full coverage
Coverage breakdown
Funding
Public broadcaster100%
Countries
United Kingdom100%
Media ownership
BBC (UK Government)100%
Avg reliability90
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 46 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 90 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

DR SAIRA BANO: Why I'll be switching many of my patients to Reta as soon as I can - the new weight-loss drug is the only hope for those unable to get over the 'Mounjaro plateau'

It is easy to forget how quickly the world of weight loss has changed. Five years ago there was no such thing as a truly effective treatment for obesity.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 16 Amplification: 0

How we score

Like
Left 46%46%Centre 42%42%Right 12%12%
BBC NewsCenter

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION. Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to...

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
+ 37 · Full coverage
Coverage breakdown
Funding
Corporate62%
Not recorded17%
Public broadcaster7%
Private7%
Nonprofit3%
Countries
United States76%
India14%
United Kingdom10%
Media ownership
Independent19%
Comcast12%
G/O Media12%
WSNS-TV6%
Google News6%
Avg reliability74
Low-credibility share4%
Fact / opinion42/0
State media0%
More analysis
Truth score: 91 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 29 Reliability: 74 Bias severity: 57 Risk: 4Sentiment: -95Sensationalism: 0 Amplification: 0

How we score

Like
Left 18%18%Centre 64%64%Right 18%18%
Yahoo NewsCenter

Garrett's three sacks injects life in the 20-13 Rams win over Washington

Star edge rusher, the reigning NFL defensive player of the year, underwent left knee surgery after season-opening loss. Barring any setbacks, Myles Garrett is expected to play for the Rams against the Washington Commanders after missing...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Apollo Global Management
+ 29 · Full coverage
Coverage breakdown
Funding
Corporate83%
Private17%
Countries
United States67%
Canada25%
United Kingdom8%
Media ownership
Independent42%
Gannett8%
News Corp8%
Patrick Soon-Shiong8%
Newsweek Media Group8%
Avg reliability69
Low-credibility share0%
Fact / opinion34/0
State media0%
More analysis
Truth score: 85 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 12 Reliability: 69 Bias severity: 0 Risk: 0Sentiment: 15Sensationalism: 2 Amplification: 0

How we score

Like
Left 20%20%Centre 70%70%Right 10%10%
BBC NewsCenter

Jaguars inflict fourth straight defeat on Ravens

ESPN’s Jeremy Fowler previews the Jaguars-Ravens matchup, Baltimore’s quarterback injuries and Trevor Lawrence’s strong start to the season. Covered by 8 outlets: 1 lean left, 5 are centre, 1 lean right, 1 are not rated.

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
+ 16 · Full coverage
Coverage breakdown
Funding
Corporate73%
Public broadcaster9%
Nonprofit trust9%
Private9%
Countries
United States64%
United Kingdom27%
Canada9%
Media ownership
Independent27%
Walt Disney Company18%
Newsweek Media Group9%
Google News9%
Apollo Global Management9%
Avg reliability74
Low-credibility share0%
Fact / opinion21/0
State media0%
More analysis
Truth score: 86 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 11 Reliability: 74 Bias severity: 33 Risk: 0Sentiment: 9Sensationalism: 1 Amplification: 0

How we score

Like
Left 36%36%Centre 9%9%Right 55%55%
PBS NewsHourLeans left

Hegseth faces impeachment push as Congress returns to Washington

There were some new faces on Capitol Hill on Monday as incoming lawmakers arrived for their orientation. Lawmakers return to Capitol Hill facing a government shutdown deadline, the farm bill, and a debt ceiling fight before Democrats...

Lean: Leans left Fact-focusedFactuality: Very highCountry: United StatesFunding: Public broadcasterOwner: PBS (Nonprofit)
+ 16 · Full coverage
Coverage breakdown
Funding
Corporate42%
Private42%
Public broadcaster8%
Nonprofit trust8%
Countries
United States92%
United Kingdom8%
Media ownership
Fox Corporation17%
Nexstar Media Group8%
Washington Examiner8%
Comcast8%
Paramount Global8%
Avg reliability68
Low-credibility share9%
Fact / opinion21/0
State media0%
More analysis
Truth score: 84 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 12 Reliability: 68 Bias severity: 20 Risk: 9Sentiment: -8Sensationalism: 1 Amplification: 0

How we score

Like
Left 40%40%Centre 40%40%Right 20%20%
TIMELeans left

Weight-Loss Drugs May Help Sleep Apnea and Arthritis

Eli Lilly reported results from new studies exploring the effects of its GLP-1 weight-loss drugs on sleep apnea and arthritis. China has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s...

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Marc Benioff
+ 2 · Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States60%
United Kingdom20%
Hong Kong20%
Media ownership
G/O Media20%
Thomson Reuters20%
Marc Benioff20%
Independent20%
Alibaba Group20%
Avg reliability77
Low-credibility share0%
Fact / opinion7/0
State media0%
More analysis
Truth score: 75 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 5 Reliability: 77 Bias severity: 33 Risk: 0Sentiment: -29Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Weight-Loss Surgery May Yield Long-Term Diabetes Remission

Patients with type 2 diabetes are more likely to reach remission after weight-loss surgery than after intensive lifestyle management, with shorter disease duration linked to better odds of remission.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

Weight-loss pill that could transform treatment for millions with a common 'snoring' condition linked to heart attacks and strokes... and mean an end to uncomfortable night-time breathing masks

Millions of sleep apnoea sufferers could one day ditch bulky breathing machines in favour of a daily weight loss pill.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Weight Loss Linked to Worse Survival in Nonmetastatic RCC

Researchers investigate how weight change after diagnosis and metabolic comorbidities affect survival in patients with nonmetastatic renal cell carcinoma.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Left 50%50%Centre 50%50%
ABC News (Australia)Center

TGA clears weight loss tablets for use in Australia

A daily Wegovy tablet has been cleared for use in Australia, with the weight loss tablet expected to hit shelves before Christmas. Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to...

Lean: Center Fact-focusedFactuality: Very highCountry: AustraliaFunding: Public broadcasterOwner: Australian Government
  • NBC News New Weight Loss Drug Could Also Treat Knee Arthritis: Study

    A recent poll found about 1-in-8 American adults say they’re currently taking GLP-1 weight loss drugs and now a study in The England Journal of Medicine finds that one drug, retatrutide, currently in trials, could...

    Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
  • Medscape Keeping the Weight Off After Stopping a GLP-1

    Weight regain is common after GLP-1 discontinuation. Experts discuss strategies that may help patients maintain their weight loss.

    Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
  • The Sydney Morning Herald First GLP-1 weight loss pill in Australia to hit market by end of the year

    Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to a surge in demand for the sought-after peptide which could hit the market by the end of this year.

    Lean: Leans left Fact-focusedFactuality: HighCountry: AustraliaFunding: CorporateOwner: Nine Entertainment
+ 3 · Full coverage
Coverage breakdown
Funding
Corporate75%
Public broadcaster25%
Countries
Australia50%
United States50%
Media ownership
Australian Government25%
Nine Entertainment25%
Independent25%
Comcast25%
Avg reliability77
Low-credibility share0%
Fact / opinion7/0
State media0%
More analysis
Truth score: 67 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 4 Reliability: 77 Bias severity: 0 Risk: 0Sentiment: -52Sensationalism: 1 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

In Weight-Loss Videos, Patients Share Their Experiences

As bariatric surgery rates decline, patient-created weight-loss videos are proliferating on social media. Clinicians advise caution but also see potential benefits.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

Stopping weight-loss jabs could DOUBLE your risk of a heart attack or stroke - and make you five times more likely to die... even if you keep the weight off, experts discover

Diabetes patients who stop taking GLP-1s may face double the risk of heart attack, stroke or early death compared with those who stay on the drugs, a large study has found.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 8 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Fox NewsRight
Truth score 38
Right 100%100%
Fox NewsRight

Popular weight-loss drugs may prevent prediabetes from turning into diabetes

A large study found GLP-1 medications like semaglutide and tirzepatide are linked to 41% lower all-cause mortality risk versus metformin in prediabetes.

Lean: Right Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Fox Corporation
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Fox Corporation100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
World
1 source

Who is covering this

The Epoch TimesRight
Truth score 17Factuality: Low
Right 100%100%
The Epoch TimesRight

First Weight-Loss Tablet Approved for Use in Australia

Low reliability sourceElevated risk

A sign bearing the logo of Novo Nordisk next to the company's factory in Hillerod, Denmark, on Nov. 12, 2025. (Sergei Gapon/AFP via Getty Images)

Lean: Right Fact-focusedFactuality: LowCountry: United StatesFunding: PrivateOwner: Epoch Media Group
Full coverage
Coverage breakdown
Funding
Private100%
Countries
United States100%
Media ownership
Epoch Media Group100%
Avg reliability35
Low-credibility share100%
Fact / opinion1/0
State media0%
More analysis
Truth score: 17 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 35 Bias severity: 0 Risk: 100Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Culture
2 sources
Truth score 56
Left 50%50%Centre 50%50%
QuartzLeans left

BMI, health conditions and medical history decide GLP-1 weight-loss eligibility

GLP-1 weight-loss drug eligibility depends on BMI, specific health conditions and medical history, and these 14 points show who FDA labels for Wegovy, Zepbound and Saxenda include and exclude

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Full coverage
Coverage breakdown
Funding
Private50%
Corporate50%
Countries
United States50%
Taiwan50%
Media ownership
G/O Media50%
Liberty Times Group50%
Avg reliability74
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 56 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 74 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
2 sources

Who is covering this

StandardCenterOxfordmailCenter
Truth score 48
Centre 100%100%
StandardCenter

Adverts promoting prescription-only weight loss pills to public are banned

The ads for Voy, Juniper and MedExpress all promoted prescription-only medicines to the public, which is banned in the UK, the ASA found.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 48 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Business
2 sources

Who is covering this

USA TODAYLeans leftNewsCenter
Truth score 55
Left 50%50%Centre 50%50%
USA TODAYLeans left

Can probiotics help with weight loss? 6 popular options to know

Can probiotics help with weight loss? 6 popular options to know USA Today

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Gannett
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States50%
India50%
Media ownership
Gannett50%
Independent50%
Avg reliability72
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 55 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 4 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Can Early Weight Loss Predict 1-Year GLP-1 Response?

Patient characteristics at baseline and weight loss in the first 3 months on a GLP-1 drug were tied to weight-loss outcomes at 1 year in patients using digital weight-management services.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 6 Amplification: 0

How we score

Like
1 source

Who is covering this

The Daily BeastLeft
Truth score 38
Left 100%100%
The Daily BeastLeft

Grammy Winner Debuts Drastic Weight Loss After Peaking at 300 Lb.

Johnny Nunez / Johnny Nunez/Getty Images for The Recording Academy DJ Khaled has revealed his three-word secret behind his major weight-loss journey: “Walk, golf, and Wegovy.” The Grammy-winning musician, 50, opened up in a Nov. 12...

Lean: Left Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: IAC
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
IAC100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MenshealthCenter
Truth score 38
Centre 100%100%
MenshealthCenter

The Next Generation of Weight-Loss Drugs Is Reshaping People’s Looks—And Not in a Flattering Way

‘Reta face’ is very real.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

Google NewsCenter
Truth score 41
Centre 100%100%
Google NewsCenter

Column | Powerful new weight-loss drug may also ease knee pain, major study finds

Column | Powerful new weight-loss drug may also ease knee pain, major study finds The Washington Post Eli Lilly Says Taltz/Zepbound Combo Shows Long-Term Efficacy in Psoriatic Arthritis Trial Yahoo Retatrutide Improves Knee OA Pain,...

Lean: Center OpinionFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Google News100%
Avg reliability75
Low-credibility share0%
Fact / opinion0/1
State media0%
More analysis
Truth score: 41 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 75 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like
Business
1 source

Who is covering this

The GuardianLeft
Truth score 45
Left 100%100%
The GuardianLeft

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment The gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms’ attention away from diabetes...

Lean: Left Fact-focusedFactuality: Very highCountry: United KingdomFunding: Nonprofit trustOwner: Scott Trust
Full coverage
Coverage breakdown
Funding
Nonprofit trust100%
Countries
United Kingdom100%
Media ownership
Scott Trust100%
Avg reliability85
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 45 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 85 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Who should prescribe weight loss drugs? IFSO says doctors’ competence, not speciality, should decide

Who should prescribe weight loss drugs? IFSO says doctors’ competence, not speciality, should decide The South First

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 8 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

India TodayCenter
Truth score 40
Centre 100%100%
India TodayCenter

Ozempic teeth: Can weight-loss injections damage your teeth and gums?

Ozempic teeth Can weightloss injections damage your teeth and gums

Lean: Center Fact-focusedFactuality: HighCountry: IndiaFunding: CorporateOwner: Living Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Living Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 6 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

HellomagazineCenter
Truth score 38
Centre 100%100%
HellomagazineCenter

Vanessa Feltz unveils unbelievable weight loss in ultra-plunging gown before daring leather quickchange

Vanessa Feltz has shown off her impressive weight loss in an ultra-plunging gown of dreams.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 12 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Team-Based Program Aids Weight Loss in Underserved Adults

A 6-month weight-loss pilot program involving doctors, a dietitian, and exercise coaches helped underserved adults with obesity lose a median of 5.5% of body weight.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Retatrutide Tops Ozempic for Weight Loss, A1c in T2D

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like